Answers are grounded in this paper and cite their sources.
Introduction. Anti-inflammatory potential of antidepressants was observed before the COVID-19 pandemic. However, it recently regained spotlight when studies with large number of patients showed that antidepressants reduced the risk of intubation and death in COVID-19 symptomatic infection. Also, the response to antidepressants seems to be more rapid in post-COVID depression that in non-COVID19 related depression. The aim of this paper to review the literature regarding the effects and mechanisms of action of antidepressants in COVID-19 infection and post-COVID sequalae, and to present a case repot of a typical outpatient with post-COVID depression. Conclusion. Post-COVID depression is a common sequela of COVID-19 infection. Selective serotonin reuptake inhibitors elicit a rapid and efficient response in patients with post-COVID depression, which may be explained by their anti-inflammatory properties. Timely screening and treatment of post-COVID psychiatric disorders can significantly decrease the burden of COVID-19 pandemic both at the individual and societal level. Also, it is discussed how the pandemic studies of antidepressant mechanisms of actions provided new insights on the aetiology of depression.
No takes yet. Share an insight, caveat, or question.
Dabetic et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: